Anti-inflammatory drug protects against lethal inflammation from COVID-19 in animal models

(The Mount Sinai Hospital / Mount Sinai School of Medicine) Mount Sinai researchers have found that a widely available and inexpensive drug targeting inflammatory genes has reduced morbidity and mortality in mice infected with SARS-CoV-2, the virus that causes COVID-19.